Jyong Biotech Ltd. - Ordinary shares

Jyong Biotech Ltd. - Ordinary shares

Share · KYG831161065 · MENS (XNAS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Jyong Biotech Ltd. - Ordinary shares
No Price
29.04.2026 19:51
Current Prices from Jyong Biotech Ltd. - Ordinary shares
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
MENS
USD
29.04.2026 19:51
2,19 USD
0,02 USD
+0,92 %
IEXG: IEX
IEX
MENS
USD
29.04.2026 19:50
2,19 USD
0,02 USD
+0,92 %
Company Profile for Jyong Biotech Ltd. - Ordinary shares Share
Jyong Biotech Ltd. is a Taiwan-based biotech firm focused on developing and commercializing plant-derived drugs targeting urinary system diseases. The company operates through its subsidiaries—Health Ever Bio-Tech, Genvace, and others—working on drug candidates like MCS‑2 (for BPH) currently in Phase III, PCP (for prostate cancer) in Phase II, and IC in pre-clinical stages

Company Data

Name Jyong Biotech Ltd. - Ordinary shares
Company Jyong Biotech Ltd. Ordinary Shares
Symbol MENS
Website https://www.jyongbio.com/
Primary Exchange XNAS NASDAQ
ISIN KYG831161065
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Fu-Feng Kuo
Market Capitalization 165 Mio
Country Taiwan
Currency USD
Employees 0,0 T
Address 23F‑3, No. 95, Section 1, Xintai 5th Road, 221 New Taipei City
IPO Date 2025-06-17

Ticker Symbols

Name Symbol
NASDAQ MENS
More Shares
Investors who hold Jyong Biotech Ltd. - Ordinary shares also have the following shares in their portfolio:
DEKA IHS MTN S 7722
DEKA IHS MTN S 7722 Bond
OTSUKA HOLDINGS CO.LTD
OTSUKA HOLDINGS CO.LTD Share